Examination of the Follicular Lymphoma International Prognostic Index (FLIPI) in the National LymphoCare Study (NLCS): A U.S. patient cohort treated predominantly in community practices.

8036 Background: FLIPI uses five prognostic factors to define 3 risk groups. Limited data exists regarding the role of FLIPI in the era of rituximab (R) and R-chemo as initial therapy Methods: NLCS...